Xconomy: Agenda: Innovation at Biotech's Epicenter


	AGENDA

	1:00 – 2:00	Registration
	2:00 – 2:10	Welcome & Introductions Regis Kelly, Director, QB3 Alex Lash, National Biotechnology Editor, Xconomy
	2:10 – 2:30	Opening Keynote: UCSF in the 21st Century Sam Hawgood, Chancellor, University of California, San Francisco
	2:30 – 2:55	One-on-One Chat: CIRM Rebooted? C. Randal Mills, President and CEO, California Institute for Regenerative Medicine Alex Lash, National Biotechnology Editor, Xconomy
	2:55 – 3:25	Discussion: Big Data for Big (And Small) Biopharma Gini Deshpande, CEO, NuMedii Dongliang Ge, Director of Bioinformatics, Gilead Sciences Rick Morrison, CEO, Comprehend Systems David Shaywitz, CMO, DNAnexus (moderator)
	3:25 – 3:55	Networking Break
	3:55 – 4:15	Solo Talk: Synthetic Biology, From DIY to Big Business Jack Newman, Co-founder and CSO, Amyris
	4:15 – 4:40	Bay Area Bloodlines: An Investor/CEO Discussion Mark Goldsmith, Partner, Third Rock Ventures Ted Love, CEO, Global Blood Therapeutics
	4:40 – 5:00	Solo Talk: Microchips and Single Cells Robert C. Jones, EVP of Research & Development, Fluidigm
	5:00 – 5:30	Discussion: Incubator/Accelerators, the Bay Area’s Latest Shared Economy Lindy Fishburne, Executive Director, Breakout Labs; SVP for Investments, Thiel Foundation Arvind Gupta, Investment Partner, SOSventures; Co-founder, IndieBio Accelerator Chris Haskell, Head of U.S. Science Hub, Bayer HealthCare Stephanie Marrus, Director of the Entrepreneurship Center, University of California, San Francisco Alex Lash, National Biotechnology Editor, Xconomy (moderator)
	5:30 – 6:30	Networking Reception


REGISTER NOW: xconomyforum71.eventbrite.com

Underwriters and Partners

Connect with Xconomy

Xconomy on Demand